Company Description
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally.
The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies.
In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines.
Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads.
It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets.
The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016.
Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
| Country | United States |
| Founded | 1970 |
| IPO Date | Sep 29, 2000 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 11,000 |
| CEO | Payman Khales |
Contact Details
Address: 5830 Granite Parkway, Suite 1150 Plano, Texas 75024 United States | |
| Phone | 214 618 5243 |
| Website | integer.net |
Stock Details
| Ticker Symbol | ITGR |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001114483 |
| CUSIP Number | 45826H109 |
| ISIN Number | US45826H1095 |
| Employer ID | 16-1531026 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Payman Khales | Chief Executive Officer, President and Director |
| Diron Smith | Executive Vice President and Chief Financial Officer |
| Lindsay Krause Blackwood J.D. | Senior Vice President, General Counsel, Chief Ethics and Compliance Officer and Corporate Secretary |
| Jim Stephens | Executive Vice President of Special Projects |
| Tom P. Thomas | Vice President, Corporate Controller and Principal Accounting Officer |
| Carol Russell | Vice President and Chief Information Officer |
| Kristen Marie Stewart C.F.A. | Director of Investor Relations |
| Kirk K. Thor Ph.D. | Executive Vice President and Chief Human Resources Officer |
| Sanjiv Arora | Senior Vice President of Strategy, Business Development and Investor Relations |
| Tony Carr | Executive Vice President of Global Quality and Regulatory Affairs |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 26, 2026 | 8-K | Current Report |
| May 22, 2026 | SD | Form - SD |
| May 22, 2026 | 8-K | Current Report |
| May 20, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| May 6, 2026 | SCHEDULE 13G | Filing |
| Apr 30, 2026 | 10-Q | Quarterly Report |
| Apr 30, 2026 | SCHEDULE 13G | Filing |
| Apr 30, 2026 | 8-K | Current Report |
| Apr 29, 2026 | SCHEDULE 13G | Filing |
| Apr 6, 2026 | ARS | Filing |